Clamor has risen around India & South Africa’s proposal seeking the waiver of Intellectual Property Rights (IPR) for easier access to COVID-19 medicines. But what choices do nations have if the nego...

Prof Manoj Pant, Director, IIFT, argues that for once, the IPR waiver on COVID vaccines should be taken as a non-political necessity in response to a once-in-a-decade event. The long term political op...